Go Pro

Assenagon Asset Management S.A. Trims Stake in Cigna Group $CI

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Assenagon Asset Management cut its Cigna stake by 78.9% in the second quarter, selling 388,259 shares and retaining 103,683 shares valued at approximately $28.6 million. Institutional investors collectively own 86.99% of Cigna.
  • Cigna reported quarterly EPS of $7.78, exceeding estimates by $0.18, while revenue rose 6.7% year over year to $70.04 billion. The company maintained fiscal 2026 EPS guidance of $30.45, versus analyst expectations of $30.51.
  • Cigna declared a quarterly dividend of $1.56, equivalent to $6.24 annually and a 2.2% yield. Analysts maintain a “Moderate Buy” consensus, with 15 Buy ratings and an average price target of $339.45, despite several recent target reductions and insider selling.
  • Five stocks we like better than Cigna Group.

Assenagon Asset Management S.A. lowered its position in Cigna Group (NYSE:CI - Free Report) by 78.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 103,683 shares of the health services provider's stock after selling 388,259 shares during the period. Assenagon Asset Management S.A.'s holdings in Cigna Group were worth $28,583,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of the business. Brighton Jones LLC increased its stake in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after purchasing an additional 318 shares during the period. Sivia Capital Partners LLC grew its holdings in shares of Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock worth $384,000 after purchasing an additional 109 shares during the last quarter. NewEdge Advisors LLC increased its stake in Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider's stock worth $7,347,000 after buying an additional 958 shares during the period. Treasurer of the State of North Carolina increased its stake in Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider's stock worth $49,204,000 after buying an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. bought a new stake in shares of Cigna Group during the second quarter valued at approximately $163,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Insider Buying and Selling

In other news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 222,213 shares of company stock valued at $64,751,950. 0.60% of the stock is owned by corporate insiders.

Cigna Group Stock Down 0.2%

NYSE:CI opened at $281.95 on Monday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company's fifty day moving average price is $286.00 and its 200-day moving average price is $281.26. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The firm has a market capitalization of $74.50 billion, a P/E ratio of 11.67, a PEG ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period last year, the firm earned $7.20 EPS. The firm's revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group's payout ratio is presently 25.82%.

Analyst Ratings Changes

Several research analysts recently issued reports on CI shares. Piper Sandler dropped their price objective on Cigna Group from $370.00 to $346.00 and set an "overweight" rating on the stock in a research note on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Barclays raised their target price on shares of Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Jefferies Financial Group lowered shares of Cigna Group from a "buy" rating to a "hold" rating and reduced their price target for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Finally, Wells Fargo & Company upped their price target on shares of Cigna Group from $305.00 to $307.00 and gave the stock an "equal weight" rating in a research report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $339.45.

Read Our Latest Research Report on CI

Cigna Group Company Profile

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines